Summary
RAS genes are the most frequently mutated oncogenes, with prominent prevalence in some of the most aggressive cancers, such as lung or pancreatic tumors. This has led to an intense effort in the development of therapies targeting RAS oncoproteins. However, after more than...
More information & hyperlinks